ATP data

MRE announced Phase II results with intravenous infusion of ATP, showing weight gain, and improvement in daily living activities and quality of life.

None of the patients met criteria for complete or partial tumor response, but tumor progression was stopped in 8 of the 15 patients for three months, and a measurable reduction in tumor burden was seen in 3 patients. ...